Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
On Oct. 16, 2026, MLAB is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5171 stocks scored that day.
Mesa Laboratories Inc /Co/ is a small-cap company with a market capitalization of $685M. It ranks number 10 by market capitalization among the 18 Industrial Instruments For Measurement, Display, and Control issuers in our coverage with a current forecast. Its P/E Ratio of 143.99x is the highest of the 9 peers that report one.
For MLAB, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 57.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 37.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, MLAB included.
Follow MLAB free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Industrial Instruments For Measurement, Display, and Control peers listed below that report each metric.
| Metric | MLAB | Rank |
|---|---|---|
| Market Cap | $685M | 10/18 |
| P/E Ratio | 143.99x | 1/9 |
| P/B Ratio | 3.63x | 8/16 |
| Dividend Yield | 0.52% | 5/9 |
| EPS | $0.85 | – |
| Book Value/Share | $33.73 | – |
| Revenue/Share | $44.63 | – |
| FCF/Share | $9.45 | – |
| Metric | MLAB | Rank |
|---|---|---|
| ROE | 2.5% | 9/17 |
| ROA | 1.1% | 9/17 |
| ROIC | 6.2% | 7/16 |
| Gross Margin | 64.2% | 5/17 |
| Operating Margin | 9.0% | 8/17 |
| Net Margin | 1.9% | 9/17 |
| EBT Margin | 3.8% | 9/17 |
| Tax Rate | 48.7% | – |
| Metric | MLAB | Rank |
|---|---|---|
| Current Ratio | 1.79x | 8/17 |
| Quick Ratio | 1.32x | 7/15 |
| D/E Ratio | 1.22x | 7/17 |
| Financial Leverage | 2.22x | 7/17 |
| Interest Coverage | 0.3x | 7/13 |
| Working Capital | $46M | 10/17 |
| Metric | MLAB | Rank |
|---|---|---|
| Operating Cash Flow | $56M | 10/17 |
| Free Cash Flow | $53M | 9/13 |
| Capital Spending | -$3M | 5/13 |
| OCF Growth YoY | 45.5% | 1/11 |
| FCF Growth YoY | 56.0% | 1/9 |
| FCF/Sales | 21.2% | 6/13 |
| CapEx/Sales | 1.1% | 10/13 |
| Metric | MLAB | Rank |
|---|---|---|
| Asset Turnover | 0.60x | 6/17 |
| Receivables Turnover | 7.3x | 7/16 |
| Inventory Turnover | 3.3x | 7/15 |
| Fixed Assets Turnover | 8.3x | 9/15 |
| Days Sales Outstanding | 50 days | 10/16 |
| Days Inventory | 111 days | 9/15 |
| Payables Period | 30 days | 11/11 |
| Cash Conversion Cycle | 131 days | 7/10 |
| Metric | MLAB | Rank |
|---|---|---|
| Total Revenue | $250M | 10/17 |
| Operating Income | $22M | 9/17 |
| Net Income | $5M | 9/17 |
| R&D Expense | $20M | 9/12 |
| SG&A Expense | $118M | 10/14 |
| Cost of Goods Sold | $89M | 12/16 |
| Metric | MLAB | Rank |
|---|---|---|
| Dividends Per Share | $0.63 | – |
| Payout Ratio | 74.1% | 2/8 |
| Shares Outstanding | 6M | – |
| Total Current Assets | $103M | 24.5% of assets |
| Cash & Short-term Investments | $31M | 7.3% of assets |
| Accounts Receivable | $34M | 8.2% of assets |
| Inventory | $27M | 6.5% of assets |
| Total Liabilities | $230M | 55.0% of assets |
| Short-term Debt | $50M | 11.9% of assets |
Companies classified under the same SEC industry code as Mesa Laboratories Inc /Co/ (Industrial Instruments For Measurement, Display, and Control): 18 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| MLAB Mesa Laboratories Inc /Co/ | ▶ | $685M |
| DHR Danaher Corp /De/ | ▼ | $161.01B |
| AME Ametek Inc/ | ▼ | $56.90B |
| KEYS Keysight Technologies, Inc. | ▶ | $56.39B |
| ROP Roper Technologies Inc | ▶ | $37.85B |
| FTV Fortive Corp | ▼ | $18.36B |
| MKSI Mks Inc | ▶ | $14.53B |
| CGNX Cognex Corp | ▲ | $9.08B |
| RAL Ralliant Corp | ▼ | $7.36B |
| ST Sensata Technologies Holding Plc | ▼ | $5.91B |
| SENS Senseonics Holdings, Inc. | ▲ | $411M |
| HURC Hurco Companies Inc | ▶ | $135M |
| SYPR Sypris Solutions Inc | ▲ | $41M |
| INIS Radnostix Inc | ▲ | $24M |
| CLIR Clearsign Technologies Corp | ▲ | $17M |
| QURT Quarta-Rad, Inc. | ▶ | $6M |
| POAS Phaos Technology Holdings (Cayman) Ltd | ▼ | $4M |
| FCUV Focus Universal Inc. | ▼ | $2M |
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MESA LABORATORIES INC /CO/ has an estimated net worth of $3.51 Million. This is based on reported shares in MESA LABORATORIES INC /CO/.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
On Oct. 16, 2026, MLAB is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5171 stocks scored that day.
For MLAB, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 57.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 37.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Mesa Laboratories Inc /Co/ forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
18 issuers in our coverage, MLAB included, share the SEC industry code Industrial Instruments For Measurement, Display, and Control. The largest are: Danaher Corp /De/ (DHR), Ametek Inc/ (AME), Keysight Technologies, Inc. (KEYS), Roper Technologies Inc (ROP), Fortive Corp (FTV), Mks Inc (MKSI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.